Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Alliance Pharma Broker Ratings



Broker Ratings for Alliance Pharma (APH)


Share Price: 62.50Bid: 61.50Ask: 62.50Change: 0.00 (0.00%)No Movement on Alliance Pharma
Spread: 1.00Spread as %: 1.63%Open: 60.75High: 62.50Low: 60.75Yesterday’s Close: 62.50


Broker Recommendations for Alliance Pharma (APH)
DateBrokerRatingOld TargetNew TargetChange
04-Dec-17numisBuy71.0071.00Reiteration
13-Sep-17Investec SecuritiesBuy-59.00New Coverage
13-Sep-17N 1 Singernot rated--Reiteration
18-Jul-17Numis SecuritiesBuy-60.00Reiteration
25-May-17Numis SecuritiesBuy-60.00Reiteration
09-May-17FinnCapBuy-65.00Reiteration
30-Mar-17Numis SecuritiesBuy-60.00Reiteration
23-Jan-17numisBuy-60.00Reiteration
14-Sep-16numisBuy-60.00Reiteration
19-Jul-16numisBuy-60.00Reiteration
13-Jul-15numisAdd48.0048.00Reiteration
13-Jul-15Canaccord GenuityHold40.0040.00Reiteration
27-May-15Numis SecuritiesAdd-48.00Downgrade
27-Mar-15FinnCapBuy-40.00Reiteration
26-Mar-15Canaccord GenuityBuy37.0040.00Reiteration


Registered members see more Alliance Pharma broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.